Results 241 to 250 of about 269,396 (285)

OGFRL1 deficiency causes CRMO via pathological osteoclastogenesis, with therapeutic response to TNF inhibitor

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives To verify the pathogenesis of the OGFRL1 loss‐of‐function variant (c.30del, p. F10Ffs*110) identified in a CRMO patient and investigate the underlying mechanism. Methods Whole exome sequencing and Sanger sequencing were performed to identify and confirm the variant.
Wen Xiong   +9 more
wiley   +1 more source

Serum Proteomic Signatures of RA Risk and Response: Analysis of the APIPPRA Trial

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To identify serum protein signatures associated with progression to rheumatoid arthritis (RA) and response to abatacept in at‐risk individuals. Methods A total of 440 serum samples from 118 APIPPRA study participants were selected from baseline to RA onset for 46 RA progressors or to study end for 72 participants who did not develop RA ...
Marianna Jasenecova   +9 more
wiley   +1 more source

Effect of Nutritional Ingredients on Disease Activation in Psoriatic Arthritis. [PDF]

open access: yesArch Rheumatol
Varkal G   +4 more
europepmc   +1 more source

Azacitidine Beyond the Bone Marrow: An Unexpected Journey Into Azacitidine-Induced Arthropathy. [PDF]

open access: yesCureus
Bandyopadhyay S   +4 more
europepmc   +1 more source

Chronic inflammatory arthritis in 22q11.2 deletion (DiGeorge) syndrome: a multicentric study. [PDF]

open access: yesOrphanet J Rare Dis
Liebling E   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy